What is Hyundai Pharmaceutical Co., Ltd.'s (004310.KS) StockRank?

MoatMap's StockRank for Hyundai Pharmaceutical Co., Ltd. (004310.KS) is 23/100, with a Sell signal. This is a composite score combining Quality (53), Value (30), and Momentum (32) factor ranks across MoatMap's 20,000+ stock universe.

Does Hyundai Pharmaceutical Co., Ltd. have an economic moat?

Hyundai Pharmaceutical Co., Ltd. (004310.KS) has a Quality factor score of 53/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Hyundai Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Hyundai Pharmaceutical Co., Ltd. (004310.KS) is Sell, based on a StockRank of 23/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Hyundai Pharmaceutical Co., Ltd. in?

Hyundai Pharmaceutical Co., Ltd. (004310.KS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

004310.KS

SELLREMOVE

Hyundai Pharmaceutical Co., Ltd. · Healthcare · South Korea · $117M · Avg Vol: $19M/d

StockRank

P/E (TTM)

—

ROE

1.5%

D/E

0.2x

Dividend %

0.5%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Hyundai Pharmaceutical is a small-scale South Korean drug maker. It lacks the global scale, R&D pipeline, and competitive moat required to compete with global pharma leaders.

COMPANY DESCRIPTION

Hyundai Pharmaceutical Co., Ltd. manufactures and markets specialty pharmaceuticals, over-the-counter (OTC) medicines, and functional health beverages. The company holds a strong competitive position in niche therapeutic areas, particularly in reproductive health, obstetrics, and hair loss treatments. It benefits from high brand equity in South Korea through its iconic functional drink, Miero Fiber, which helps fund its ongoing pharmaceutical R&D.

FINANCIAL SUMMARY (USD)

Year	2021	2022	2023	2024	2025	CAGR
Revenue	—	107M	119M	116M	126M	5.6%
EPS	-0.08	-0.00	0.15	-0.01	—	—
Shares	—	32M	32M	32M	26M	-18.3%
Debt	10M	26M	26M	32M	33M	35.1%
Equity	—	57M	56M	52M	54M	-1.7%
Op CF	—	8M	-3M	-2M	-81,153	—
Inv CF	—	-7M	-2M	-6M	-6M	—
Fin CF	—	5M	-4M	4M	474,587	—

PRICE (1M)+6.1%

SMA 50SMA 200

$5.75

RSI (14)

67.7

52W High

$10.48

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

4.6%55.7

ROE

1.5%47.4

GP/Assets

24.8%56.2

Op. Margin

1.6%47.8

FCF/Assets

3.9%65.4

Piotroski

—55.7

Int. Cover

2.2x46.3

D/E Ratio

0.21x51.7

Current Ratio

2.20x41.2

Value

P/E (TTM)

—N/A

EV/EBITDA

32.8x10.7

P/FCF

42956.7x30.9

P/B

2.3x49.7

P/S

2.1x66.3

Div Yield

0.5%15.5

Momentum

52W High %

55%30.5

RS 6M

-94%9.7

SMA 50/200

1.08x76.8

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$117M

P/E (Forward)

—

Gross Margin

37.4%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 004310.KS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
004310.KS	Hyundai Pharmaceutical Co., Ltd.(you)	$117M	23	SELL
256840.KQ	BNC KOREA, Inc.	$131M	19	STRONG SELL
214390.KS	Kyongbo Pharmaceutical Co., Ltd	$91M	27	SELL
058820.KQ	CMG Pharmaceutical Co., Ltd.	$107M	14	STRONG SELL
000520.KS	Samil Pharmaceutical Co.,Ltd	$105M	14	STRONG SELL
271980.KS	Jeil Pharmaceutical Co.,Ltd	$115M	36	HOLD
003220.KS	Daewon Pharmaceutical Co., Ltd.	$124M	37	HOLD
102460.KS	REYON Pharmaceutical Co., Ltd.	$125M	37	HOLD
002390.KS	HANDOK Inc.	$73M	17	STRONG SELL
170900.KS	Dong-A ST Co., Ltd.	$256M	25	SELL

Peer medians: ROE -1.3% · P/E 17.7x · Gross margin 43.6%

Hyundai Pharmaceutical Co., Ltd. (004310.KS) — Stock Score Summary

Hyundai Pharmaceutical Co., Ltd. (004310.KS) has a MoatMap StockRank of 23/100 based on Quality (53/100), Value (30/100), and Momentum (32/100) factor scores. The current signal is SELL. Hyundai Pharmaceutical is a small-scale South Korean drug maker. It lacks the global scale, R&D pipeline, and competitive moat required to compete with global pharma leaders.

Key Financial Metrics

Price	$5.75
Market Cap	$117M
Price/Book	2.31
Return on Equity	1.5%
Return on Invested Capital	4.6%
Debt/Equity	20.50
Gross Margin	37.4%
Operating Margin	1.6%
Revenue Growth	5.0%
Dividend Yield	0.5%
Free Cash Flow	$3K

Hyundai Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Hyundai Pharmaceutical Co., Ltd.’s (004310.KS) StockRank?: MoatMap’s StockRank for Hyundai Pharmaceutical Co., Ltd. (004310.KS) is 23/100, with a Sell signal. It is a composite of Quality (53), Value (30), and Momentum (32) factor ranks across MoatMap’s 20,000+ stock universe.
Does Hyundai Pharmaceutical Co., Ltd. have an economic moat?: Hyundai Pharmaceutical Co., Ltd. (004310.KS) has a Quality factor score of 53/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Hyundai Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Hyundai Pharmaceutical Co., Ltd. (004310.KS) is Sell, based on a StockRank of 23/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Hyundai Pharmaceutical Co., Ltd. in?: Hyundai Pharmaceutical Co., Ltd. (004310.KS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).